Neogen Corporation - Common Stock (NEOG)
4.8300
-0.5900 (-10.89%)
NASDAQ · Last Trade: Jul 29th, 5:24 PM EDT
Detailed Quote
Previous Close | 5.420 |
---|---|
Open | 4.960 |
Bid | 4.700 |
Ask | 4.830 |
Day's Range | 4.690 - 4.960 |
52 Week Range | 3.870 - 18.58 |
Volume | 8,183,407 |
Market Cap | 1.04B |
PE Ratio (TTM) | -2.166 |
EPS (TTM) | -2.2 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 5,803,258 |
Chart
About Neogen Corporation - Common Stock (NEOG)
Neogen Corporation is a company that specializes in developing and marketing innovative solutions for food and animal safety. Its product portfolio includes a wide range of diagnostic tests, natural antiseptics, and other technologies designed to detect foodborne pathogens, allergens, and other contaminants. Neogen serves diverse markets, including food processors, restaurants, and agriculture. By providing tools that help ensure the safety and quality of food products, Neogen plays a critical role in promoting public health and supporting higher standards in food production and processing. Read More
News & Press Releases
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · July 29, 2025
NEW YORK - July 29, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Neogen Corporation (NASDAQ: NEOG) of a class action securities lawsuit.
Via TheNewswire.com · July 29, 2025
Shares of life sciences company Neogen (NASDAQ:NEOG)
fell 10.2% in the morning session after the company reported disappointing fourth-quarter financial results, which showed a decline in revenue and adjusted earnings that fell short of analyst expectations. The food and animal safety company announced that revenue for the quarter ended May 31, 2025, decreased by 4.8% to $225.5 million compared to the prior year. Neogen also posted a significant net loss of $612.2 million, which it attributed mainly to a non-cash goodwill impairment charge related to its acquisition of the former 3M Food Safety Division. On an adjusted basis, net income was $0.05 per share, a drop from $0.10 in the same period last year and below Wall Street's consensus estimates. Management cited softer market conditions and the effects of inflation as key factors behind the weak performance.
Via StockStory · July 29, 2025
Law Offices of Howard G. Smith reminds investors of the upcoming September 16, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) common stock between January 5, 2023 through June 3, 2025, inclusive (the “Class Period”).
By Law Offices of Howard G. Smith · Via Business Wire · July 29, 2025
Life sciences company Neogen (NASDAQ:NEOG) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 4.8% year on year to $225.5 million. The company’s full-year revenue guidance of $830 million at the midpoint came in 3.4% above analysts’ estimates. Its non-GAAP profit of $0.05 per share was 44.4% below analysts’ consensus estimates.
Via StockStory · July 29, 2025
Neogen Corporation (NASDAQ: NEOG) announced today the results of the fourth quarter ended May 31, 2025.
By Neogen Corporation · Via Business Wire · July 29, 2025
SAN FRANCISCO, July 29, 2025 (GLOBE NEWSWIRE) -- Girard Sharp LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of former or current investors of 3M Company (“3M”) who received shares of Neogen Corporation (“Neogen” or the “Company”) in connection with Neogen’s acquisition of 3M’s Food Safety Business on September 1, 2022 (“Merger”).
By Girard Sharp LLP · Via GlobeNewswire · July 29, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (NASDAQ:NEOG), Alto Neuroscience, Inc. (NYSE:ANRO), RxSight, Inc. (NASDAQ:RXST), and Replimune Group, Inc. (NASDAQ:REPL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · July 28, 2025
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) common stock between January 5, 2023 through June 3, 2025, inclusive (the “Class Period”). Neogen investors have until September 16, 2025 to file a lead plaintiff motion.
By The Law Offices of Frank R. Cruz · Via Business Wire · July 28, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 28, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · July 28, 2025
NEW YORK - July 28, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Neogen Corporation (NASDAQ: NEOG) of a class action securities lawsuit.
Via TheNewswire.com · July 28, 2025
Neogen Corporation (NASDAQ: NEOG) today announced the launch of Molecular Detection Assay - Listeria Right Now™, a rapid, enrichment-free solution for detecting Listeria species in the environment. The new tool is being introduced at the 2025 International Association for Food Protection (IAFP) Annual Meeting, taking place July 27–30 at the Huntington Convention Center in Cleveland, Ohio.
By Neogen Corporation · Via Business Wire · July 28, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · July 28, 2025
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Neogen Corporation (NASDAQ: NEOG) common stock between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”), have until September 16, 2025 to seek appointment as lead plaintiff of the Neogen class action lawsuit. Captioned Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation, No. 25-cv-00802 (W.D. Mich.), the Neogen class action lawsuit charges Neogen as well as certain of Neogen’s top executives with violations of the Securities Exchange Act of 1934.
By Robbins Geller Rudman & Dowd LLP · Via Business Wire · July 28, 2025
Life sciences company Neogen (NASDAQ:NEOG)
will be reporting results this Tuesday before the bell. Here’s what you need to know.
Via StockStory · July 27, 2025
SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Neogen Corporation (NASDAQ: NEOG) securities between January 6, 2023 and June 3, 2025. Neogen is a food safety company that manufactures and markets products and services dedicated to food and animal safety.
By Robbins LLP · Via GlobeNewswire · July 25, 2025
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) common stock between January 5, 2023 through June 3, 2025, inclusive (the “Class Period”). Neogen investors have until September 16, 2025 to file a lead plaintiff motion.
By Glancy Prongay & Murray LLP · Via Business Wire · July 25, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · July 25, 2025
NEW YORK - July 25, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Neogen Corporation (NASDAQ: NEOG) of a class action securities lawsuit.
Via TheNewswire.com · July 25, 2025
Shares of life sciences company Neogen (NASDAQ:NEOG)
jumped 3.4% in the morning session after the company announced the appointment of Mike Nassif as its new Chief Executive Officer and President.
Via StockStory · July 24, 2025
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) common stock between January 5, 2023 through June 3, 2025, inclusive (the “Class Period”). Neogen investors have until September 16, 2025 to file a lead plaintiff motion.
By Law Offices of Howard G. Smith · Via Business Wire · July 24, 2025
PHILADELPHIA, July 24, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · July 24, 2025